(Q40707628)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201631%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

title

Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201631%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201631%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Ching-Sheng Hsu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201631%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Shih-Jer Hsu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201631%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Hung-Chia Chen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201631%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Chen-Hua Liu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201631%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Jenher Jeng

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201631%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Chun-Jen Liu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201631%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Pei-Jer Chen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201631%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Ding-Shinn Chen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201631%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

8 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201631%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

published in

Hepatology international

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201631%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201631%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201631%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

171-179

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26201631%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12072-012-9390-3

20 February 2020

exact match

0 references

cites work

Diagnosis, management, and treatment of hepatitis C

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Associations between serum lipids and hepatitis C antiviral treatment efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Interferon-alfa, interferon-lambda and hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Serotyping of hepatitis C virus in chronic type C hepatitis in Taiwan: correlation with genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Antiviral action of ribavirin in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Metabolic profiles in patients with chronic hepatitis C: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Inflammation and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

The lipid droplet is an important organelle for hepatitis C virus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9390-3

Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy.

21 January 2018

1 reference

12 December 2020

Transmission of hepatitis C virus in Asia: past and present perspectives

1 reference

12 December 2020

Side effects of therapy of hepatitis C and their management

1 reference

12 December 2020

New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a

1 reference

12 December 2020

National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002--June 10-12, 2002.

1 reference

12 December 2020

Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan

1 reference

12 December 2020

Correlation between insulin resistance and hepatitis C viral load

1 reference

12 December 2020

Diagnosis and classification of diabetes mellitus

1 reference

12 December 2020